NO840065L - Fremgangsmaate ved fremstilling av 17-estere av clobetasol - Google Patents
Fremgangsmaate ved fremstilling av 17-estere av clobetasolInfo
- Publication number
- NO840065L NO840065L NO840065A NO840065A NO840065L NO 840065 L NO840065 L NO 840065L NO 840065 A NO840065 A NO 840065A NO 840065 A NO840065 A NO 840065A NO 840065 L NO840065 L NO 840065L
- Authority
- NO
- Norway
- Prior art keywords
- epoxy
- dione
- diene
- methylpregna
- esters
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 24
- 229960002842 clobetasol Drugs 0.000 title claims description 11
- FCSHDIVRCWTZOX-DVTGEIKXSA-N clobetasol Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O FCSHDIVRCWTZOX-DVTGEIKXSA-N 0.000 title 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 16
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 13
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical group [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- 229940070710 valerate Drugs 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- 239000012359 Methanesulfonyl chloride Substances 0.000 claims description 4
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229960004703 clobetasol propionate Drugs 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 1
- 125000003700 epoxy group Chemical group 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- FGWYWKIOMUZSQF-UHFFFAOYSA-N 1,1,1-triethoxypropane Chemical compound CCOC(CC)(OCC)OCC FGWYWKIOMUZSQF-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- GBDXNHBVYAMODG-DEGNENOVSA-N 16-β methyl epoxide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]23[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]3O2 GBDXNHBVYAMODG-DEGNENOVSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 2
- 229960002537 betamethasone Drugs 0.000 description 2
- 150000003945 chlorohydrins Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- -1 steroid epoxides Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- XUXVVQKJULMMKX-UHFFFAOYSA-N 1,1,1-trimethoxypentane Chemical compound CCCCC(OC)(OC)OC XUXVVQKJULMMKX-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- AVGAIPMGSIOHFZ-UHFFFAOYSA-N dichloromethane;2-propan-2-yloxypropane Chemical compound ClCCl.CC(C)OC(C)C AVGAIPMGSIOHFZ-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000003682 fluorination reaction Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000005905 mesyloxy group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- NIXKBAZVOQAHGC-UHFFFAOYSA-N phenylmethanesulfonic acid Chemical compound OS(=O)(=O)CC1=CC=CC=C1 NIXKBAZVOQAHGC-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- BQFPCTXLBRVFJL-UHFFFAOYSA-N triethoxymethylbenzene Chemical compound CCOC(OCC)(OCC)C1=CC=CC=C1 BQFPCTXLBRVFJL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20334/83A IT1194178B (it) | 1983-03-29 | 1983-03-29 | Processo per la preparazione di 17-esteri di clobetasolo e composti ottenuti |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO840065L true NO840065L (no) | 1984-10-01 |
Family
ID=11165811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO840065A NO840065L (no) | 1983-03-29 | 1984-01-09 | Fremgangsmaate ved fremstilling av 17-estere av clobetasol |
Country Status (10)
| Country | Link |
|---|---|
| JP (2) | JPS59205397A (sv) |
| CA (1) | CA1220468A (sv) |
| CH (1) | CH661930A5 (sv) |
| DK (1) | DK42884A (sv) |
| FI (1) | FI840344A (sv) |
| IT (1) | IT1194178B (sv) |
| NL (1) | NL8400910A (sv) |
| NO (1) | NO840065L (sv) |
| SE (1) | SE8400145L (sv) |
| YU (1) | YU54684A (sv) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111944002A (zh) * | 2020-07-29 | 2020-11-17 | 河南利华制药有限公司 | 一种倍氯米松二丙酸酯中间体及制备方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108727458A (zh) * | 2018-05-10 | 2018-11-02 | 浙江仙居仙乐药业有限公司 | 一种17-丙酸酯的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1253831A (en) * | 1968-01-19 | 1971-11-17 | Glaxo Lab Ltd | 9alpha,21-DIHALOPREGNANE COMPOUNDS |
| JPS51125372A (en) * | 1975-03-31 | 1976-11-01 | Taisho Pharmaceut Co Ltd | Aprocess for preparing pregnane steroid-17-ester-21-halides |
-
1983
- 1983-03-29 IT IT20334/83A patent/IT1194178B/it active
-
1984
- 1984-01-09 NO NO840065A patent/NO840065L/no unknown
- 1984-01-10 CH CH113/84A patent/CH661930A5/it not_active IP Right Cessation
- 1984-01-12 SE SE8400145A patent/SE8400145L/sv not_active Application Discontinuation
- 1984-01-19 CA CA000445603A patent/CA1220468A/en not_active Expired
- 1984-01-27 FI FI840344A patent/FI840344A/fi not_active Application Discontinuation
- 1984-01-31 JP JP59015956A patent/JPS59205397A/ja active Pending
- 1984-01-31 JP JP59015957A patent/JPS59205399A/ja active Granted
- 1984-01-31 DK DK42884A patent/DK42884A/da not_active Application Discontinuation
- 1984-03-22 NL NL8400910A patent/NL8400910A/nl not_active Application Discontinuation
- 1984-03-28 YU YU00546/84A patent/YU54684A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111944002A (zh) * | 2020-07-29 | 2020-11-17 | 河南利华制药有限公司 | 一种倍氯米松二丙酸酯中间体及制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| IT1194178B (it) | 1988-09-14 |
| JPS59205399A (ja) | 1984-11-20 |
| JPS59205397A (ja) | 1984-11-20 |
| FI840344A0 (fi) | 1984-01-27 |
| DK42884D0 (da) | 1984-01-31 |
| CH661930A5 (en) | 1987-08-31 |
| DK42884A (da) | 1984-09-30 |
| IT8320334A0 (it) | 1983-03-29 |
| SE8400145L (sv) | 1984-09-30 |
| SE8400145D0 (sv) | 1984-01-12 |
| YU54684A (en) | 1986-10-31 |
| CA1220468A (en) | 1987-04-14 |
| NL8400910A (nl) | 1984-10-16 |
| JPS6228160B2 (sv) | 1987-06-18 |
| FI840344A (fi) | 1984-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890000761B1 (ko) | 스테로이드의 방향성 헤테로사이클릭 에스테르 및 이의 제조방법 | |
| JPS6252759B2 (sv) | ||
| NO791141L (no) | 17beta-tiokarboksylsyreestere av 4-halogen-3-oksyandrost-4-enes, og fremgangsmaate til deres fremstilling | |
| HU227378B1 (en) | Process for preparing delta 9,11 -chloro corticosteroids | |
| US7718793B2 (en) | Method for the preparation of 6-α fluoro corticosteroids | |
| NO803450L (no) | Nye 6alfa-fluor-prednisolon-17,21-diestere og fremgangsmaate ved fremstilling derav | |
| EP1395603B1 (en) | Preparation of flumethasone and its 17-carboxyl androsten analogue | |
| NO840065L (no) | Fremgangsmaate ved fremstilling av 17-estere av clobetasol | |
| EP0061416B1 (en) | Process for the preparation of delta 9(11)- and delta 16-21-chloro-20-keto steroids of the pregnane and d-homopregnane series and their use as intermediates for the synthesis of highly effective corticoids | |
| US4525303A (en) | Process for preparation of steroids | |
| US4342702A (en) | Metallated halogenated acetylene corticoid synthesis | |
| NO327138B1 (no) | Fremgangsmate for fremstilling av flutikasonpropionat som krystallinsk polymorf form 1 | |
| AU2002310616A1 (en) | Preparation of flumethasone and its 17-carboxyl androsten analogue | |
| JP2004534795A5 (sv) | ||
| DK146017B (da) | Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser | |
| EP0027192B1 (en) | A process for the preparation of 4,6-dien-3-one steroids | |
| US4357279A (en) | Preparation of corticoids from 17-keto steroids | |
| KR20040088050A (ko) | 6.알파.,9.알파-디플루오로-17.알파.-(1-옥소프로폭시-11.베타.-히드록시-16.알파.-메틸-3-옥소-안드로스트-1,4-디엔-１７.베타.-카보티오산을 제조하는 방법 | |
| US5602248A (en) | Process for preparation of 9α-chloro-11β-formyloxypregna-3,20-diones | |
| NO132189B (sv) | ||
| SU828969A3 (ru) | Способ получени производных9-фТОРпРЕдНизОлОНА | |
| EA000731B1 (ru) | ПОЛУЧЕНИЕ (11β, 16β)-21-(3-КАРБОКСИ-3-ОКСОПРОПОКСИ)-11-ГИДРОКСИ-2'-МЕТИЛ-5'Н-ПРЕГНА-1,4-ДИЕНО[17,16-D]-ОКСАЗОЛ-3,20-ДИОНА | |
| NO131346B (sv) | ||
| WO2001055171A1 (en) | Mometasone and its preparation | |
| NO127669B (sv) |